Cortez-Dias Nuno, Martins Susana, Belo Adriana, Fiuza Manuela
Serviço de Cardiologia do Hospital de Santa Maria, Lisboa, Portugal.
Rev Port Cardiol. 2009 May;28(5):499-523.
Hypertension (HT) is the most common modifiable risk factor for cardiovascular disease, and HT management and control is of major importance in preventive strategies. However, patterns of antihypertensive (AHT) treatment have never been evaluated in Portugal.
To estimate the prevalence of HT and to characterize its management in a primary care setting, identifying the most frequently used drugs and evaluating regional variations in treatment patterns.
The VALSIM study is a descriptive cross-sectional study performed in a primary care setting, involving 719 general practitioners (GPs) and representative of all regions of Portugal. The first two patients aged > or = 18 years consulting their GP on each day were asked to participate, irrespective of the reason for the consultation. After informed consent was obtained, a questionnaire was used to collect sociodemographic, clinical and laboratory data. Two blood pressure (BP) measurements were taken after a 5-minute rest period in a seated position. HT was defined as BP higher than 140/90 mmHg or use of antihypertensive medication.
A total of 16,856 subjects were evaluated (mean age 58.1 +/- 15.1 years; 61.3% women). The prevalence of HT adjusted for age and gender was 42.62% (males: 43.09%, females: 42.19%). Of the 9,189 hypertensive patients under treatment, the proportion receiving one, two or three or more drug classes was 47.62%, 36.16% and 16.22% respectively. The classes most frequently used in monotherapy were angiotensin receptor blockers (ARBs, 16.9%), angiotensin-converting enzyme inhibitors (ACEIs, 14.41%) and diuretics (5.85%). The most common associations of two classes were ARB-diuretic (11.82%), ACEI-diuretic (11.79%), ACEI-calcium channel blpcker (CCB, 2%), CCB-diuretic (1.81%) and ARB-CCB (1.53%). The most frequently used AHT drugs were diuretics (47.4%), ARBs (43%) and ACEIs (39.2%). CCBs were used in 18.9% and beta-blockers in 16.2% only. Different patterns of treatment were identified according to gender, age and region of residence. Diuretics were used more in the elderly, women, and in the Azores (61.9%) and the Alentejo (58.3%). ARBs were used preferentially in middle-aged patients, men and in the Northern region (48.6%).
There is considerable regional variation in treatment patterns. The proportion of hypertensive patients under monotherapy is still very high. Increasing the use of combination antihypertensive therapy would probably improve HT control in the population. Furthermore, increased use of CCBs would probably also be useful, as they are used less than would be expected, compared to other European countries.
高血压(HT)是心血管疾病最常见的可改变风险因素,高血压的管理与控制在预防策略中至关重要。然而,葡萄牙从未对降压(AHT)治疗模式进行过评估。
估计初级保健机构中高血压的患病率,并描述其管理情况,确定最常用的药物,评估治疗模式的地区差异。
VALSIM研究是一项在初级保健机构中进行的描述性横断面研究,涉及719名全科医生(GP),代表了葡萄牙所有地区。每天前来咨询全科医生的头两名年龄≥18岁的患者被邀请参与,无论咨询原因如何。获得知情同意后,使用问卷收集社会人口学、临床和实验室数据。在坐位休息5分钟后进行两次血压(BP)测量。高血压定义为血压高于140/90 mmHg或使用降压药物。
共评估了16856名受试者(平均年龄58.1±15.1岁;61.3%为女性)。经年龄和性别调整后的高血压患病率为42.62%(男性:43.09%,女性:42.19%)。在9189名接受治疗的高血压患者中,接受一种、两种或三种及以上药物治疗的比例分别为47.62%、36.16%和16.22%。单药治疗中最常用的药物类别是血管紧张素受体阻滞剂(ARB,16.9%)、血管紧张素转换酶抑制剂(ACEI,14.41%)和利尿剂(5.85%)。两种药物最常见的联合使用是ARB-利尿剂(11.82%)、ACEI-利尿剂(11.79%)、ACEI-钙通道阻滞剂(CCB,2%)、CCB-利尿剂(1.81%)和ARB-CCB(1.53%)。最常用的AHT药物是利尿剂(47.4%)、ARB(43%)和ACEI(39.2%)。CCB的使用比例为18.9%,β受体阻滞剂仅为16.2%。根据性别、年龄和居住地区确定了不同的治疗模式。利尿剂在老年人、女性以及亚速尔群岛(61.9%)和阿连特茹地区(58.3%)使用较多。ARB在中年患者、男性以及北部地区(48.6%)优先使用。
治疗模式存在相当大的地区差异。单药治疗的高血压患者比例仍然很高。增加联合降压治疗的使用可能会改善人群中的高血压控制。此外,增加CCB的使用可能也会有用,因为与其他欧洲国家相比,CCB的使用低于预期。